Emerging evidence has assigned an important role to sleep as a modulator of metabolic
homeostasis. The impact of variations in sleep duration, sleep-disordered breathing, and …

Background Obstructive sleep apnea syndrome (OSAS) has been indicated to contribute to
the development of cardiovascular disease; however, the underlying mechanism remains …

Rationale: Continuous positive airway pressure (CPAP) and mandibular advancement
device (MAD) therapy are commonly used to treat obstructive sleep apnea (OSA) …

Background Altered sleep parameters, such as duration and quality, play an important role
in the pathogenesis and progression of cardiovascular diseases, as well as in all-cause …

Background: Obstructive sleep apnea (OSA) may lead to the development of hypertension
and therapy with continuous positive airway pressure (CPAP) can promote reduction in …

A wide range of clinical consequences may be associated with obstructive sleep apnea
(OSA) including systemic hypertension, cardiovascular disease, pulmonary hypertension …

Background Brachycephalic dogs (BD) are prone to congenital upper airway obstruction
(brachycephalic syndrome, BS). In humans suffering from sleep apnea, upper airway …

Sleep-disordered breathing (SDB) can be a sequela of stroke caused by vascular injury to
vital respiratory centers, cerebral edema, and increased intracranial pressure of space …

Background Arterial stiffness and its hemodynamic consequences are known to be
associated with increased cardiovascular morbidity and mortality. Pulse wave velocity …

Obstructive sleep apnea (OSA) is associated with increased arterial stiffness, a cumulative
indicator of arterial health. Continuous positive airway pressure (CPAP) is the gold standard …